GSK Turnaround Story
- ByTalkmarkets-
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.
A better than forecast, but still 2nd highest ever, UK borrowing figure for April failed to move the needle for the FTSE on Tuesday. The UK index was unchanged after the bell, flat...
The US is packing a lot into the final week of April, including a Fed meeting, some key Q1 data, and a stacked earnings calendar. USThere are a few major events this week,...
GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Sell | Neutral | Buy |
| Technical Indicators | Buy | Buy | Buy | Neutral | Strong Buy |
| Summary | Buy | Neutral | Neutral | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 9,700.00 | 9,712.00 | 9,292.00 | +514.0 | +5.59% | 88.56K | London | |||
| 126.50 | 126.92 | 125.58 | 0.00 | 0.00% | 66.26M | London | |||
| 404.00 | 404.00 | 393.00 | +10.50 | +2.67% | 564.80K | London | |||
| 286.00 | 286.00 | 286.00 | 0.00 | 0.00% | 0.00 | London | |||
| 3,066.00 | 3,097.00 | 3,019.00 | +5.0 | +0.16% | 3.42M | London | |||
| 986.20 | 986.20 | 937.20 | +51.60 | +5.52% | 4.37M | London | |||
| 4.397 | 4.495 | 4.20 | -0.203 | -4.31% | 1.60M | London | |||
| 1,122.50 | 1,130.00 | 1,092.00 | +36.00 | +3.31% | 1.70M | London | |||
| 244.60 | 244.90 | 235.30 | +8.60 | +3.64% | 10.51M | London | |||
| 733.00 | 739.40 | 710.00 | +29.00 | +4.12% | 2.85M | London | |||
| 3,551.00 | 3,561.00 | 3,362.00 | +192.0 | +5.72% | 830.70K | London | |||
| 9,200.00 | 9,210.00 | 8,650.00 | +474.0 | +5.43% | 832.86K | London | |||
| 47.34 | 48.06 | 45.14 | +1.34 | +2.91% | 3.44M | London | |||
| 1,637.00 | 1,640.00 | 1,547.00 | +90.50 | +5.85% | 1.25M | London | |||
| 208.50 | 209.50 | 201.00 | +6.50 | +3.22% | 556.20K | London |